Sonendo, Inc.
Close on Oct 19, 2026
- Market cap
- $606.54K
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2024 Ended Sep 30, 2024 | Oct 10, 2024 | Before market open | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | During market hours | $8.30M | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 8, 2024 | During market hours | $7.00M | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 11, 2024 | During market hours | $11.70M | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Oct 10, 2023 | Before market open | $10.40M | – | – |
| Q2 FY2023 Ended Jun 30, 2023 | Aug 9, 2023 | During market hours | $11.00M | – | – |
| Q1 FY2023 Ended Mar 31, 2023 | May 9, 2023 | During market hours | $10.70M | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 8, 2023 | During market hours | – | – | – |
| Q3 FY2022 Ended Sep 30, 2022 | Nov 9, 2022 | During market hours | – | – | – |
| Q2 FY2022 Ended Jun 30, 2022 | Aug 10, 2022 | During market hours | – | – | – |
| Q1 FY2022 Ended Mar 31, 2022 | May 10, 2022 | During market hours | – | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Jan 10, 2022 | During market hours | – | – | – |
Press releases
Announcements Sonendo filed with the SEC
Sonendo, Inc. Reports Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Sonendo, Inc. Announces Preliminary Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Sonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue Guidance
Results of operations · EX-99.1 to Form 8-K
RECONCILIATION OF GAAP TO NON-GAAP
Results of operations · EX-99.2 to Form 8-K
SONENDO STRENGTHENS LEADERSHIP WITH KEY STRATEGIC APPOINTMENTS
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Sonendo, Inc. Reports First Quarter 2024 Financial Results and Announces Strategic Reset Priorities
Results of operations · EX-99.1 to Form 8-K
Sonendo Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and
Results of operations · EX-99.1 to Form 8-K
SONENDO ANNOUNCES DEPARTURE OF CHIEF FINANCIAL OFFICER
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Sonendo Divests TDO® Software and Amends Credit Agreement
Material agreement · Acquisition or disposition completed · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
Sonendo, Inc. Announces Suspension of NYSE Trading, Will Commence Trading on the OTCQX Effective November 22, 2023
Listing notice · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Sonendo, Inc. Reports Third Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Sonendo, Inc. Announces Preliminary Revenue Results for the Third Quarter 2023
Results of operations · EX-99.1 to Form 8-K
Sonendo, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Trading Share Price Listing Rule
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
Sonendo, Inc. Reports Second Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Sonendo's Enhanced CleanFlow Procedure Instrument Now Indicated for Use on Anterior Teeth
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Sonendo, Inc. Reports First Quarter 2023 Financial Results
Results of operations · EX-99 to Form 8-K
SONENDO ANNOUNCES NEW LEADERSHIP IN OPERATIONS AND R&D
Executive or director change · Regulation FD disclosure · EX-99 to Form 8-K
Sonendo Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and
Results of operations · EX-99 to Form 8-K
OUR MISSION Saving Teeth. Improving Lives. WHAT THIS MEANS Establish the GentleWave procedure as the standard of care for tooth decay, with an initial focus on transforming root canal therapy.
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
PIPSTEK LLC, A SUBSIDIARY OF SONENDO, FILES PATENT INFRINGEMENT LAWSUIT AGAINST BIOLASE
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Sonendo, Inc. Reports Third Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Sonendo® Announces Next Generation GentleWave® G4 System
Regulation FD disclosure · EX-99.1 to Form 8-K
Sonendo, Inc. Announces $63 Million Private Placement
Material agreement · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Sonendo, Inc. Reports Second Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Sonendo, Inc. Announces Executive Management Team Changes
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Sonendo, Inc. Reports First Quarter 2022 Financial Results
Results of operations · EX-99.1 to Form 8-K
Sonendo Announces Launch of CleanFlow Technology to Improve Doctor and Patient Experience
Regulation FD disclosure · EX-99.1 to Form 8-K
Sonendo Inc. Reports Fourth Quarter 2021 Financial Results and
Results of operations · EX-99.1 to Form 8-K
Sonendo, Inc. Announces Preliminary Revenue Results for the Fourth Quarter and Full-Year 2021
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Our Mission Improve Quality of Life by Saving Teeth and Stopping the Progression of Tooth Decay Establish the GentleWave Procedure as the Standard of Care for Tooth Decay, with an Initial Focus on Transforming Root Canal Therapy
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Sonendo, Inc. Reports Third Quarter 2021 Financial Results and Issues Full Year 2021 Revenue Guidance
Results of operations · EX-99.1 to Form 8-K
Sonendo Appoints Raj Pudipeddi to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K